6531 - 6540 of 8606 Results
Title
Year
-
OPENTitle: Long-Term Dementia Risk in Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 103Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000209699Best OA location URL: https://escholarship.org/content/qt59g3g428/qt59g3g428.pdfCitation Count: 21
- In vivo detection of substantia nigra and locus coeruleus volume loss in Parkinson’s disease using neuromelanin-sensitive MRI: Replication in two cohorts2023OPENTitle: In vivo detection of substantia nigra and locus coeruleus volume loss in Parkinson’s disease using neuromelanin-sensitive MRI: Replication in two cohortsJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 18Issue #: 4Start Page: e0282684End Page: e0282684Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0282684Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0282684&type=printableCitation Count: 14
- A Novel Negative Allosteric Modulator Selective for GluN2C/2D-Containing NMDA Receptors Inhibits Synaptic Transmission in Hippocampal Interneurons2017OPENTitle: A Novel Negative Allosteric Modulator Selective for GluN2C/2D-Containing NMDA Receptors Inhibits Synaptic Transmission in Hippocampal InterneuronsJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 9Issue #: 2Start Page: 306End Page: 319Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.7b00329Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5924706Citation Count: 50
- Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study2023OPENTitle: Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 22Issue #: 5Start Page: 407End Page: 417Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(23)00109-6Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/133500Citation Count: 440
- The Mitochondrial Rhomboid Protease PARL Is Regulated by PDK2 to Integrate Mitochondrial Quality Control and Metabolism2017OPENTitle: The Mitochondrial Rhomboid Protease PARL Is Regulated by PDK2 to Integrate Mitochondrial Quality Control and MetabolismJournal Name: Cell ReportsPublisher: Elsevier BVVol: 18Issue #: 6Start Page: 1458End Page: 1472Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.celrep.2017.01.029Best OA location URL: https://www.cell.com/article/S2211124717300669/pdfCitation Count: 78
- Motor and nonmotor features of p.A53T alpha-synuclein PD vs idiopathic PD: longitudinal data from the PPMI study2025OPENTitle: Motor and nonmotor features of p.A53T alpha-synuclein PD vs idiopathic PD: longitudinal data from the PPMI studyJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 272Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00415-024-12836-wBest OA location URL: https://doi.org/10.1007/s00415-024-12836-wCitation Count: 0
- The LRRK2 kinase substrates RAB8a and RAB10 contribute complementary but distinct disease-relevant phenotypes in human neurons2024OPENTitle: The LRRK2 kinase substrates RAB8a and RAB10 contribute complementary but distinct disease-relevant phenotypes in human neuronsJournal Name: Stem Cell ReportsPublisher: Elsevier BVVol: 19Issue #: 2Start Page: 163End Page: 173Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.stemcr.2024.01.001Best OA location URL: https://doi.org/10.1016/j.stemcr.2024.01.001Citation Count: 8
-
OPENTitle: Metabolomics of sebum reveals lipid dysregulation in Parkinson’s diseaseJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-021-21669-4Best OA location URL: https://www.nature.com/articles/s41467-021-21669-4.pdfCitation Count: 166
-
RESTRICTEDTitle: Parkinson's disease mutant Miro1 causes mitochondrial dysfunction and dopaminergic neuron lossJournal Name: BrainPublisher: Oxford University Press (OUP)Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/brain/awaf051Best OA location URL: https://doi.org/10.1093/brain/awaf051Citation Count: 6
-
OPENTitle: LRRK2 activation in idiopathic Parkinson’s diseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 10Issue #: 451Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.aar5429Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6344941Citation Count: 547